Akèy › Gliyòm › Illinois › Chicago
Etid klinik pou Gliyòm nan Chicago, IL
13 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Ap rekriteFaz 1/2
- University of Chicago Comprehensive Cancer Center, Chicago
Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- University of Chicago, Chicago
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Ap rekriteFaz 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
Ap rekriteFaz 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Chicago
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
Ap rekriteFaz 1
- Northwestern Medicine, Chicago
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Ap rekriteFaz 1/2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Ap rekriteFaz 1 bonèVolontè an sante akeyi
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ap rekriteFaz 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- Northwestern Memorial Hospital, Chicago
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Ap rekriteFaz 1
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Etid Gliyòm nan lòt vil
- New York City, NY25 etid
- Houston, TX23 etid
- Boston, MA20 etid
- Washington, DC19 etid
- Philadelphia, PA16 etid
- Miami, FL15 etid
- Columbus, OH15 etid
- San Francisco, CA14 etid
- Durham, NC12 etid
- Seattle, WA11 etid
- Los Angeles, CA10 etid
- St. Louis, MO10 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.